Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
Cerna K, Duricova D, Lukas M, Kolar M, Machkova N, Hruba V, Mitrova K, Kubickova K, Kostrejova M, Jirsa J, Kastylova K, Peterka S, Vojtechova G, Lukas M.
Cerna K, et al. Among authors: vojtechova g.
Crohns Colitis 360. 2023 Jul 25;5(4):otad040. doi: 10.1093/crocol/otad040. eCollection 2023 Oct.
Crohns Colitis 360. 2023.
PMID: 38028954
Free PMC article.